Accurate Investment Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-332
Closed -$24K 425
2018
Q2
$24K Sell
332
-753
-69% -$53.2K 0.02% 197
2018
Q1
$82K Buy
1,085
+3
+0.3% +$238 0.06% 102
2017
Q4
$78K Buy
1,082
+2
+0.2% +$152 0.06% 104
2017
Q3
$88K Buy
1,080
+259
+32% +$19.8K 0.07% 96
2017
Q2
$58K Buy
821
+101
+14% +$6.72K 0.05% 117
2017
Q1
$49K Buy
720
+710
+7,100% +$49.9K 0.04% 118
2016
Q4
$1K Sell
10
-607
-98% -$45.1K ﹤0.01% 291
2016
Q3
$49K Buy
617
+3
+0.5% +$244 0.04% 118
2016
Q2
$51K Buy
614
+4
+0.7% +$355 0.05% 107
2016
Q1
$56K Buy
610
+3
+0.5% +$271 0.05% 144
2015
Q4
$61K Buy
+607
New +$63.2K 0.06% 102

Other funds holding GILD

Accurate Investment Solutions's GILD Position: Q3 2018 in Review

Accurate Investment Solutions sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 332 shares — an estimated $24K sold.

Accurate Investment Solutions first reported a position in GILD in Q4 2015 and held it in 11 quarters. The position peaked at $88K in Q3 2017. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Accurate Investment Solutions reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Accurate Investment Solutions sold 332 Gilead Sciences shares in Q3 2018, an estimated $24K.
  • Accurate Investment Solutions first reported a position in Gilead Sciences in Q4 2015 and held it in 11 quarters.
  • Accurate Investment Solutions's Gilead Sciences position peaked at $88K in Q3 2017.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Accurate Investment Solutions's 13F filing for Q3 2018, filed 5 Oct 2018.